Using an immunocompetent mouse model and the syngeneic 4MOSC head and neck squamous cell carcinoma model, CHMP2A was knocked out (KO) via CRISPR/Cas9 in 4MOSC1 cells. Here, CHMP2A is linked to head and neck squamous cell carcinoma.